As of Oct 8, 2026 close
- Market cap
- $98.76M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.71$3.06
- Volume (live)
- -
- Avg. volume (3M)
- 1.35M
Milestone Pharmaceuticals (MIST) Stock Price & Financial Analysis
Milestone Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.71 - $0.77 |
|---|---|
| 52-Week High | $3.06 |
| 52-Week Low | $0.71 |
| Open | $0.72 |
| Volume (last close) | 1.23M |
| Average Volume (3M) | 1.35M |
| Market Cap | 98.76M |
|---|---|
| Shares Outstanding | 138.69M |
| Price to Sales (P/S) | 42.15 |
| Price to Book (P/B) | 5.42 |
| EV/EBITDA | -0.95 |
| Revenue (TTM) | 2.34M |
|---|---|
| Net Income (TTM) | -84.01M |
| Free Cash Flow (TTM) | -61.26M |
| EPS (TTM) | $-0.80 |
| Profit Margin | -3585.62% |
| Operating Margin | -3353.01% |
| Return on Equity (ROE) | -461.14% |
| Debt to Equity | 7.80 |
| 50-Day MA | $1.02 |
|---|---|
| 200-Day MA | $1.48 |
| 1-Year Change | −65.93% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Milestone Pharmaceuticals at a Glance
Milestone Pharmaceuticals (MIST) has a market capitalization of $98.76M. The stock trades at 42.1× sales. Over the trailing twelve months it lost $84.01M on revenue of $2.34M and burned $61.26M of free cash flow.
It holds $169.73M in cash and securities against $142.02M of debt, a net cash position of $27.70M.
Milestone Pharmaceuticals does not currently pay a dividend.
The share price is down 65.9% over the past year. At $0.77 it sits near the bottom of its 52-week range of $0.71 to $3.06, below its 200-day moving average of $1.48.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.50, 749.7% above the latest close.
Frequently Asked Questions About Milestone Pharmaceuticals
What is the current stock price for MIST?
As of the Oct 9, 2026 close, MIST stock trades at $0.77. The 52-week range is $0.71–$3.06, with a day range of $0.71–$0.77.
What is the P/E ratio for MIST?
The P/E ratio (Price-to-Earnings) for MIST is shown in the Key Statistics section. This valuation metric helps compare Milestone Pharmaceuticals Inc. to industry peers.
Does MIST pay dividends?
Milestone Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MIST?
Based on 5 analysts, the consensus for MIST is Buy.
What is the market cap of MIST?
Milestone Pharmaceuticals's market capitalization is $106.1M, classifying it as a micro-cap company. Milestone Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.